laboratory surveys (e.g. Belk and Sunderman, 1947; Wootton and King, 1953; Tonks, 1963) ; they can also demonstrate local lack of reliability all too readily by submitting the same specimen to a laboratory under two different names. Imprecision in chemical work exists particularly when analyses are performed singly (or at most in duplicate), as is the usual practice in overworked clinical biochemistry laboratories.
It may sometimes appear a disadvantage to clinical biochemists that they should work in laboratories that can have their analytical shortcomings objectively displayed, but at least they have the opportunity-by means of quality control programmes-to define the degree of confidence that medical staff can place upon the results of their observations. This is in sharp contrast to many essentially qualitative aspects of the art of medicine, some of which can only have their correctness confirmed at operation or at autopsy, and it is for the laboratory to prove that the clinical state of patients is no longer the best method for detecting errors in laboratory performance, as was suggested by Peenen and Lindberg (1965) . This attitude should nowadays be as dangerous as it is unsound, since it takes insufficient account of the fact that most clinical biochemistry laboratories operate programmes of quality control; furthermore, it implies that the clinical state of the patient can be used as the justification for rejecting laboratory results even though the patient's condition had originally presented a problem in diagnosis or management that required investigation by chemical methods for its solution.
Quality control in laboratories and decision-making by doctors
Quality control programmes operated in the laboratory can be used to provide certain objective information about the reliability of results, and these data are needed by clinicians if they are going to be able to interpret results in other than an empirical manner. For the purposes of decision, clinicians basically need clear answers to the following three questions:
1. Does a particular result on an individual patient differ from what is normally found? The answer to this question requires the laboratory to provide 104
Paper read at the National Meeting of the Association of Clinical Biochemists on Quality Control in Clinical Biochemistry, Leeds, April,1969. Many laboratories report that workloads for examinations have been doubling every four to five years (Lathe and Mitchell, 1966; Flynn et al., 1968) . These investigations have mostly been requested for diagnostic purposes, or for helping to control the treatment of patients, but growing interest in the presymptomatic recognition of disease and the performance of biochemical profiles will give rise to even greater numbers of investigations, either as part of an initial screening assessment or in the follow-up of the considerable proportion of abnormalities revealed by biochemical screening for which no clinical explanation is immediately forthcoming (Whitby, 1969) . Since doctors are almost inevitably going to be presented with more biochemical information about their patients, it is worth considering what they require from the labboratory and how far these requirements are met at present.
Doctors require investigations to be readily available without the need for extensive justification, and expect the results of laboratory work to be reliable and to be provided sufficiently quickly to be of value in influencing decision-making. In many hospitals, however, it is questionable whether these requirements are being regularly met; many clinicians can recall requests for investigations that cannot be met at all, or requests that have taken inordinately long to be processed, and others where the reliability of the results has been seriously open to question. Expressed in the simplest terms, the medical objective of quality control programmes in clinical biochemistry must be to improve standards of patient care. Unreliable laboratory results can lead to wrong decisions about the management of patients, sometimes with fatal results. Doctors, once alerted to the possibility of unreliability in a laboratory's work, may choose thereafter to ignore chemical results whenever they fail to fit in with clinical assessments of the condition of patients, even though decisions to disregard results of chemical investigations may also have fatal consequences.
Clinicians can support their critical attitude to the results of biochemical investigations by referring to the published findings of several inter-data about normal ranges, taking account, where relevant, of age, sex, race etc. These depend on both the biological variation of a particular chemical constituent and the laboratory's analytical precision at the time the method was set up; their validity demands that the laboratory's performance thereafter be maintained at such a level as not to influence the normal range, at least until an improved method is introduced. Most laboratories state 'normal ranges', but this information does not always clearly distinguish between compounds with a Gaussian and those with a skewed distribution. The use of normal ranges for comparative purposes makes no allowance for ways in which lack of care in the collection of specimens from individual patients can affect the interpretation of results; this aspect of quality control, in which clinical staff can play a very important part, will be discussed later.
Instead of presenting results in units of concentration. which requires comparison with sets of normal values. the expression of results on a probability basis is being increasingly advocated. This expression of probability can make use of the data in Table 1 . Table 1 . Significance of differences (after Campbell and Owen, 1967) .
Ratio obtained after Probability (%) that the dividing the difference ratio is due to analytical between two figures by error. the appropriate standard deviation A B shows that two sets of results obtained on specimens collected under identical conditions have, on the basis of single analyses. to differ by 2.75 x the analytical standard deviation for the change to be significant at the 5 % level, assuming that the error curve for the determination is Gaussian.
Relatively few laboratories provide doctors with data about the analytical precision they claim. and still fewer maintain these data constantly under review. As noted by Campbell and Owen (1967) . 'laboratories have good days and bad days' and clinical staff may be quick to spot the bad days. particularly if the laboratory does not keep cumulative records of its work (Whitby and Owen. 1965; Flynn and Vernon, 1965) since the doctors in charge of patients then have a better opportunity to assess results of serial observations than do the laboratory staff themselves.
3. What is the probability that a result. which is subject to error. differs from a fixed value? Campbell and Owen (1967) suggest that doctors may need to make decisions on the basis of such assessments. which again make use of Table 1 . column A. but on this occasion the analytical standard deviation is employed for calculating the appropriate ratio. This third type of decision-making prior to selecting a particular therapeutic regime is much less common in practice than either of the two previous examples, and is even more dependent upon a full assessment of all factors affecting the clinical situation.
The contribution of clinicians to improved quality oflaboratory performance
Laboratory staff help doctors to interpret the results of chemical investigations by providing basic information about the quality of laboratory performance. Clinicians. for their part. have an important role to play in maintaining the standards of laboratory work; they can contribute to the output of more reliable results and so to the value of information generated by clinical biochemistry laboratories. Improvements in requesting procedures (e.g, using preprinted request forms bearing patient identification preferably in machine-readable and visible form), the issue of simple instructions for the collection of specimens, and reduction in the variety of specimen containers can all help provide the laboratory with properly identified and satisfactorily collected specimens. Mistakes include the collection of specimens from the wrong patient or mislabelling of specimen containers, failure to take account of a patient's dietary history or intake of drugs, failure to collect specimens at the correct time of day, use of the wrong skin-cleansing agent, excessive venous stasis, collection of 'blood' from a limb receiving an intravenous infusion, loss of part of a timed collection of urine or faeces, and the use of the wrong specimen preservative etc. Delays in transport to the laboratory may also render specimens unsuitable for analysis, or give rise to misleading results if the analyses are carried out. Many of these problems will remain until the general introduction of trained specimen collectors (some laboratories undertake this task themselves) but even then difficulties may persist in relation to dietary control, or the intake of drugs, or the complete collection of specimens extending over periods of hours or days.
At present, most of the potential sources of error connected with the supply of specimens lie outside the direct control of the laboratory staff. However, mistakes that cause results for one patient to be attributed to another patient only sometimes occur on hospital wards, and clinicians maintain that, in most instances, errors due to interchange of results occur in the laboratory itself; this is all too easy if discipline in the handling of AutoAnalyzer cups is insufficiently rigid. The mixing up of samples between patients represents the worst type of failure in the overall arrangements for controlling the performance of chemical analyses. These mistakes are clearly potentially lethal, and the continuing possibility of their occurrence emphasises the importance of devising practicable means for identifying specimens positively from the time of collection right through to the time the corresponding report is considered and entered into that individual's case record.
The presentation of reports
Just as doctors can help laboratories by providing appropriate specimens, properly identified, so the laboratory can contribute further to medical aspects of quality control by presenting results promptly and legibly on clean reports; dirty reports engender lack of confidence. The units should be readily intelligible; clinicians are not altogether aware of the pitfalls associated with the use of international units for enzyme activity measurements. Delays in the issue of results lead to telephone calls or other enquiries disruptive to the laboratory's work, and errors in transcription often occur when results are issued by telephone. These errors must all be accepted as shortcomings in the laboratory's performance, as seen from the medical point of view, and their importance stems from the fact that results which were required sufficiently urgently to merit a telephone call frequently relate to patients who are seriously ill and for whom decisions about treatment cannot be further delayed.
Ideally reports should be typed, and should involve a minimum of manual transcription; no-carbon-required combined request and report forms minimise transcription errors (Flynn et al., 1968) , but computer-generated reports based on systems incorporating machine-readable request forms (e.g. Peacock et al., 1965; Whitehead, Becker and Peters, 1968 ) have additional advantages. Clinical staff are responsible for matching each report with the appropriate patient, and extracting from the reports information relevant to their decision-making. With the growing volume of data provided by biochemistry laboratories, research into methods of reducing this data into the best form for decision-making is urgently needed, and will prove almost as important medically as the maintenance of reliable performance by the laboratory.
From time to time laboratories issue reports for which there is no clinical explanation immediately apparent, or which the clinician regards as manifestly inaccurate. It is important that relationships and methods of communication between clinical and laboratory staff should be sufficiently good for clinicians to feel anxious to discuss these results with their colleagues in the laboratory immediately-the tendency to ignore unexplained abnormalities is all too prevalent, but the clinician should understand that these might provide evidence of poor quality of performance in the laboratory that had been undetected by the laboratory's own programme of quality control. This consideration makes it a duty for the clinician to discuss results falling into these categories, and laboratory staff must be prepared to accept the criticism which could arise if mistakes are revealed by these discussions.
Clinically acceptable limits 0/laboratory error Tonks (1963) suggested a formula for calculating allowable limits of error which assumed that errors should not exceed one quarter of the normal range. More recently, Barnett (1968) suggested that the desirable degree of precision was achieved by those methods for which the standard deviation did not exceed one twelfth to one twentieth of the appropriate normal range; imprecision of these amounts would respectively make the apparent ranges for a method 5.4 % to 2 % larger than the true range.
These statements suffer from lack of knowledge about normal ranges, but they do provide interim goals for laboratories to achieve and maintain, bearing in mind that the requirements for improved reliability in performance must also take into account the medical need for results to be provided in real time if they are to play any useful part in decisionmaking. More attention, perhaps, should therefore be paid to surveys of clinical opinion about acceptable limits of error (Campbell and Owen, 1967) . Even when these goals have been achieved, laboratories taking part in screening programmes for the presymptomatic detection of disease may still need to secure further improvement in the quality of their performance if results of quantitative measurements are to be compared on two or more occasions spread over a number of years, since individuals will be serving as their own controls in these attempts at detecting the development of minor but nevertheless significant changes in biochemical patterns. Biological variability of populations will not apply to these particular comparisons; instead, analytical unreliability will be the limiting factor, assuming conditions for the collection of specimens have been standardised. Medical interest in screening is increasing, and this will demand high standards of reliability in chemical results. CONCLUSION Quality control in clinical biochemistry does not apply only to the performance of laboratory work. It begins, for each specimen submitted for investigation, at the time a doctor decides that he would like to investigate someone by means of chemical investigations, and it continues right through to the time the corresponding report is considered and acted upon. Data based on quality control assessments of analytical performance are essential for the detailed interpretation of results, but many other aspects of quality control (notably collection and transport of suitable specimens) depend at least partly upon education of doctors by clinical biochemists in the requirements for the best performance of laboratory examinations. This educative role of the clinical biochemist has not been sufficiently stressed in the past.
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At present some clinicians ignore results which do not fit in with their clinical assessments of patients; while this practice continues, clinical biochemists are faced with a challenge, since it must be admitted that past analytical performance has left much to be desired. Against this tendency to criticise past performance may be set the idea that clinical biochemistry is becoming increasingly 'all Auto-Analyzers and computers' (Hamilton, 1965) , and the inference that such laboratories should nowadays at least be able to be reliable figure factories, if their staff will only agree to automate everything. Unfortunately, the widespread adoption of Auto-Analyzers has only partially solved the problems of unreliability in the analytical performance of clinical biochemistry laboratories (Gowenlock, 1969) , and computers cannot altogether make good the deficiencies in data that they may be used to process.
